First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
Article in The Lancet Haematology (March 2024)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Article in The Lancet Haematology (March 2024)
Article in Cureus (March 2024)
Article in Annals of Hematology (October 2023)